Buchumschlag

Methodological Considerations in Evaluating CTRP12 as a Biomarker for In‐Stent Restenosis

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Saleha Khattak, Syed Muhammad Rayyan, Syed Huzaifa Khan
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2026
Schlagworte:	Clinical Cardiology
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Methodological Considerations in Assessing HALP Score as a Prognostic Marker in Rheumatic Mitral Stenosis
von: Muhammad Talha, et al.
Veröffentlicht: (2026)

Critique on “Evaluation of the Presence of Native Valvular Disease in Patients With Atrial Fibrillation Using the EHRA (Evaluated Heartvalves, Rheumatic, or Artificial) Classification”
von: Arooha Javed, et al.
Veröffentlicht: (2025)

Changes of Serum CTRP12 in Patients With Coronary Artery Disease After the Treatment of Percutaneous Coronary Intervention and Its Relationship With In‐Stent Restenosis
von: Botao Zhao, et al.
Veröffentlicht: (2026)

Advancing Equity in Left Atrial Appendage Occlusion Outcomes for Hispanic/Latino Patients
von: Syed Muhammad Rayyan, et al.
Veröffentlicht: (2025)

Generalizability of Low‐Voltage Zone‐Based Risk Scores After Atrial Fibrillation Ablation
von: Laiba Anwar, et al.
Veröffentlicht: (2026)

Case Ascertainment and Exposure Classification in Acute Myocardial Infarction Mortality Studies Involving Psychoactive Substance Use
von: Noor‐ul‐Eman Haider, et al.
Veröffentlicht: (2025)

Methodological Considerations Regarding the Prognostic Utility of “Life's Essential 8” in Sleep Disorder Populations: A Letter to the Editor
von: Fatima Masood Khan, et al.
Veröffentlicht: (2026)

Methodological Considerations and Evidence Interpretation in the Phase III Evaluation of the Absnow Biodegradable ASD Occluder
von: Saad Arif, et al.
Veröffentlicht: (2026)

Methodological Considerations Regarding Voluntary Slow Breathing Exercise in Hypertensive Populations
von: Kaya Oguz Kaan
Veröffentlicht: (2026)

Methodological Considerations in Interpreting Mortality Trends in Aortic Dissection Among Hypertensive Adults
von: Hamna Bibi, et al.
Veröffentlicht: (2026)

Real‐World Clinical Performance of a Novolimus‐Eluting Stent Versus a Sirolimus‐Eluting Stent
von: Chun‐Chin Chang, et al.
Veröffentlicht: (2024)

“Bridging Guidelines and Real World Barriers: Reflections on GDMT Optimization in Heart Failure”
von: Ibadullah Tahir, et al.
Veröffentlicht: (2025)

Evaluation of Small Vessel Bifurcation Stenting Using the Double‐Kissing Culotte and Culotte Technique in Acute Coronary Syndrome: 12‐Month Clinical Outcomes
von: Mateusz Barycki, et al.
Veröffentlicht: (2024)

Trends in Chronic Ischemic Heart Disease‐Related Mortality in Older Adults With Atrial Fibrillation (1999–2023): A CDC WONDER Database Analysis
von: Muhammad Shaheer Bin Faheem, et al.
Veröffentlicht: (2026)

Nuanced Considerations in Immediate Versus Staged Multivessel PCI: Implications for Clinical Practice and Guideline Development
von: Hassan E Muhammad, et al.
Veröffentlicht: (2025)

Temporal Trends in the Outcomes of Percutaneous Coronary Intervention With Zotarolimus Eluting Stents Versus Everolimus Eluting Stents: A Meta‐Analysis of Randomized Controlled Trials
von: Jawad Basit, et al.
Veröffentlicht: (2024)

Stent Thrombosis: A Narrative Review From Pathophysiology to Therapy
von: Emanuele Cecchi, et al.
Veröffentlicht: (2026)

Methodological Concerns Regarding the Meta‐Analysis of Cranberry Consumption and Blood Pressure
von: Shaher Yar, et al.
Veröffentlicht: (2026)

Reconsidering the Prognostic Role of the HALP Score in Rheumatic Mitral Stenosis
von: Muhammad Talha, et al.
Veröffentlicht: (2026)

The Prognostic Value of Platelet‐Albumin‐Bilirubin Score in Patients Undergoing Transcatheter Aortic Valve Replacement
von: Farman Ullah Khan, et al.
Veröffentlicht: (2025)

Comparison of Single‐Coil Versus Dual‐Coil Implantable Cardioverter Defibrillator Devices: A Systematic Review and Meta‐Analysis of Efficacy and Extraction‐Related Outcomes
von: Muhammad Fawad Tahir, et al.
Veröffentlicht: (2025)

Underestimation of Stent Efficacy: Untreated Artery Events Distort Coronary Intervention Outcomes
von: Mauricio Rigodanzo Mocha, et al.
Veröffentlicht: (2025)

Clopidogrel Versus Aspirin as Monotherapy Following Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome Receiving a Drug‐Eluting Stent: A Systematic Literature Review and Meta‐Analysis
von: Dirk Sibbing, et al.
Veröffentlicht: (2024)

Bridging With Low‐Molecular‐Weight Heparin Versus Antiplatelet Therapy in Patients Undergoing Noncardiac Surgery After Percutaneous Coronary Intervention: A Comprehensive Review
von: Syed Javaid Iqbal, et al.
Veröffentlicht: (2024)

Machine Learning Constructed Based on Patient Plaque and Clinical Features for Predicting Stent Malapposition: A Retrospective Study
von: Qianhang Xia, et al.
Veröffentlicht: (2024)

Trends in Mortality Due to Cardiovascular Diseases Among Patients With Parkinson's Disease in the United States: A Retrospective Analysis
von: Muzamil Akhtar, et al.
Veröffentlicht: (2025)

Is Ticagrelor‐Related Dyspnea a Liability or a Biomarker of Response?
von: Abdülmelik Birgün, et al.
Veröffentlicht: (2026)

Long‐Term Effectiveness of a Stent‐Less Strategy With Drug Coated Balloon in Coronary Artery Disease: 3‐Year Follow‐Up of a Prospective All‐Comers Observational Study
von: Ludovic Meunier, et al.
Veröffentlicht: (2025)

States With Highest and Lowest Cardiovascular Disease‐Related Mortality in the United States (1999−2019): Top and Bottom 3
von: Muhammad Umer Sohail, et al.
Veröffentlicht: (2026)

Circulating Levels of Calprotectin as a Biomarker in Patients With Coronary Artery Disease: A Systematic Review and Meta‐Analysis
von: Tara Reshadmanesh, et al.
Veröffentlicht: (2024)

Efficacy and safety of semaglutide in patients with heart failure with preserved ejection fraction and obesity
von: Ayesha Rehman, et al.
Veröffentlicht: (2024)

“Reassessing CT‐Verified Micra Pacing Locations: Methodological Limitations and Future Clinical Directions”
von: Ibadullah Tahir, et al.
Veröffentlicht: (2026)

“A Biomarker‐Based Scoring System to Assess the Presence of Obstructive Coronary Artery Disease in Patients With Myocardial Infarction”
von: María Jesús Espinosa Pascual, et al.
Veröffentlicht: (2025)

The Potential Role of Baseline FT3/FT4 Ratio as a Prognostic Biomarker for Patients With Ischemic Non‐Obstructive Coronary Artery Disease
von: Feipeng Wu, et al.
Veröffentlicht: (2026)

A Novel Clinical Score Integrating Low‐Voltage Zones and Biomarkers Predicts Atrial Fibrillation Recurrence Post‐Ablation
von: Ying Han, et al.
Veröffentlicht: (2025)

Methodological Concerns Regarding a Recent Meta‐Analysis of Direct Oral Anticoagulants Versus Vitamin K Antagonists in Non‐Valvular Atrial Fibrillation
von: Omar Khalid Samir, et al.
Veröffentlicht: (2026)

Acute Physiological Response Versus Chronic Clinical Benefit: A Methodological Concern in the Meta‐Analysis by Cheng et al.
von: Hira Bhurgri, et al.
Veröffentlicht: (2026)

Incorporating Inflammation Biomarker‐Driven Multivariate Predictive Model for Coronary Microcirculatory Dysfunction in Acute Myocardial Infarction Following Emergency Percutaneous Coronary Intervention
von: Zhuoya Yao, et al.
Veröffentlicht: (2024)

Unmasking Arrhythmia Mortality: A 25‐Year Analysis of Trends and Disparities in the United States (1999–2023)
von: Bazil Azeem, et al.
Veröffentlicht: (2025)

The Neutrophil‐to‐Lymphocyte Ratio Is an Independent Inflammatory Biomarker for Adverse Events in Patients With Atrial Fibrillation: Insights From the Murcia AF Project II (MAFP‐II) Cohort Study
von: Eva Soler‐Espejo, et al.
Veröffentlicht: (2025)